Home › NDC Lookup › Ingredients › Memantine Hydrochloride › 70771-1119-06
Memantine Hydrochloride 5 mg Tablet, Film Coated, 60-count — NDC 70771-1119-06 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Memantine Hydrochloride 5 mg Tablet, Film Coated, 60-count — NDC 70771-1119-6 (Billing 70771-1119-06)

by Zydus Lifesciences Limited · 60 TABLET, FILM COATED in 1 BOTTLE

This is a package of 60 tablets of Memantine Hydrochloride 5 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since Sep 2017 and currently FDA-listed.

NDC 70771-1119-06
🏷️ FDA NDC (as labeled) 70771-1119-6 billing pads the package segment with a zero
This package
Contains60-count Pack sizes5 compare ↓
Also priced by: Part D plans $0.1890/unit — full pricing hub ↓
Product page 70771-1119-00 Also comes in: 1 tablet 70771-1119-4 100 tablets 70771-1119-1 500 tablets 70771-1119-5 1000 tablets 70771-1119-0
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70771-1119-6 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
70771 labeler · 1119 product · 6 package
Package marketed since
Sep 28, 2017
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0372578004057, 0372578003050
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Memantine Hydrochloride (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Mar 24, 2026 — Failed Dissolution Specifications (The Harvard Drug Group LLC) · FDA recall D-0485-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70771-1119-6
Product NDC 70771-1119
11-digit billing NDC 70771111906
RxCUI 996561, 996571
UNII JY0WD0UA60
UPC 0372578004057, 0372578003050
Application # ANDA090961
SPL Set ID 514421f3-f525-43e8-aecc-8b2bbffd00dc
Established class (EPC) N-methyl-D-aspartate Receptor Antagonist
Mechanism of action NMDA Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-09-28
Route ORAL
Dosage form TABLET, FILM COATED
Substance MEMANTINE HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS
Quick answers
  • RxCUI (RxNorm): 996561
Why two NDCs? The FDA registers this code as 70771-1119-6 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1119-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class N-methyl-D-aspartate Receptor Antagonist
Drug family (ATC) Anticholinesterases, Other anti-dementia drugs
How it works NMDA Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • Memantine treats moderate to severe dementia of the Alzheimer’s type. It helps manage symptoms, but it has not been shown to prevent or slow the underlying nerve damage.
  • Take it by mouth as your prescriber directs. The dose usually starts low and goes up over several weeks. Tablets and oral solution can be taken with or without food. If you miss a...
  • The most common are dizziness, headache, confusion and constipation. Tell your doctor if they bother you or don’t settle. Seek help quickly for a seizure, a severe skin reaction, u...
  • Many people take it with donepezil, which showed no interaction in studies. Be careful with amantadine, ketamine and dextromethorphan, and with sodium bicarbonate or carbonic anhyd...
📖 Read our full Memantine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.1890 $11.34 / 60 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70771-1119-00 70771-1119-0 Main listing 1000 TABLET, FILM COATED in 1 BOTTLE 2017-09-28 — Active
70771-1119-01 70771-1119-1 100 TABLET, FILM COATED in 1 BOTTLE 2017-09-28 — Active
70771-1119-04 70771-1119-4 100 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED in 1 BLISTER PACK 2017-09-28 — Active
70771-1119-05 70771-1119-5 500 TABLET, FILM COATED in 1 BOTTLE 2017-09-28 — Active
70771-1119-06 You're viewing this 60 TABLET, FILM COATED in 1 BOTTLE 2017-09-28 — Active

Pack size FAQ

What quantity is in this package?
This is a 60-count package — 60 tablet, film coated in 1 bottle.
How does this package differ from NDC 70771-1119-01?
Both are Memantine Hydrochloride 5 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 60-count one, while NDC 70771-1119-01 is the 100 tablets package.
What NDC number is used to bill for this package of Memantine Hydrochloride 5 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
memantine hydrochloride 5 mg 00591-3870-44 Actavis 100 tablets $0.079 — Availability likely —
Memantine Hydrochloride 5 mg 00832-1112-60 Upsher-Smith 60 tablets $0.079 AB Availability likely —
Memantine Hydrochloride 5 mg 00904-6505-06 Major 50 tablets $0.079 AB Availability likely —
Memantine Hydrochloride 5 mg 29300-0171-05 Unichem 500 tablets $0.079 AB Availability likely —
Memantine Hydrochloride 5 mg 33342-0297-09 Macleods 60 tablets $0.079 AB Availability likely —
Memantine Hydrochloride 5 mg 50268-0587-13 AvPAK 1 tablet $0.079 AB Availability likely —
Memantine 5 mg 60687-0173-57 American 60 tablets $0.079 AB Availability likely —
Memantine Hydrochloride 5 mg 61442-0192-05 Carlsbad 500 tablets $0.079 AB Availability likely —
memantine 5 mg 62135-0895-60 Chartwell 60 tablets $0.079 — Availability likely —
memantine hydrochloride 5 mg 65162-0173-06 Amneal 60 tablets $0.079 AB Availability likely —
Memantine hydrochloride 5 mg 68180-0229-07 Lupin 60 tablets $0.079 AB Availability likely —
Memantine 5 mg 72603-0118-01 NorthStar 60 tablets $0.079 AB Availability likely —
Memantine 5 mg 00615-8192-39 NCS 30 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 27241-0070-05 Ajanta 500 tablets — AB FDA listed —
memantine hydrochloride 5 mg 31722-0807-02 Camber 200 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 46708-0451-10 Alembic 100 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 47335-0321-08 Sun 100 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 50090-5926-00 A-S 60 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 50090-6291-00 A-S 60 tablets — AB FDA listed —
memantine hydrochloride 5 mg 50090-7348-00 A-S 60 tablets — AB FDA listed —
memantine hydrochloride 5 mg 52605-0071-10 POLYGEN 1000 tablets — AB Discontinued —
Memantine hydrochloride 5 mg 53746-0173-10 Amneal 1000 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 55111-0596-01 Dr. 100 tablets — AB FDA listed —
memantine hydrochloride 5 mg 55154-2666-00 Cardinal 10 tablets — — FDA listed —
Memantine Hydrochloride 5 mg 55154-4151-00 Cardinal 10 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 62332-0075-10 Alembic 100 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 63629-2513-01 Bryant 500 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 63629-2514-01 Bryant 60 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 65862-0652-03 Aurobindo 10 tablets — — FDA listed —
Memantine Hydrochloride 5 mg 67046-1471-03 Coupler 30 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 70518-3338-00 REMEDYREPACK 30 tablets — AB Discontinued —
Memantine Hydrochloride 5 mgthis 70771-1119-06 Zydus 60 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 71335-1732-01 Bryant 30 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 71335-2013-01 Bryant 30 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 71610-0911-60 Aphena 90 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 71610-0979-80 Aphena 180 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 72162-2003-05 Bryant 500 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 72189-0294-30 DirectRx 30 tablets — AB FDA listed —
Memantine Hydrochloride 5 mg 72578-0003-01 Viona 100 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
On the market since
Sep 2017
📍
2026
Currently FDA-listed
9 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeCapsule
ImprintZF;40
Size11 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII O7TSZ97GEP
    A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS LIFESCIENCES LTD
FDA applicationANDA090961 (ANDA)
Labeler code70771
First marketedSep 2017
Product typeHuman Prescription Drug
Portfolio720 products on file

More NDCs from Zydus Lifesciences Limited labeler code 70771

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 Package Label / Principal Display Panel
📄 Package Label / Principal Display Panel 44 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1119-5 in bottle of 500 tablets Memantine Hydrochloride Tablets USP, 5 mg Rx only 500 tablets NDC 70771-1120-5 in bottle of 500 tablets Memantine Hydrochloride Tablets USP, 10 mg Rx only 500 tablets Memantine Hydrochloride Tablets Memantine Hydrochloride Tablets

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 1 tablet (70771-1119-04), 100 tablets (70771-1119-01), 500 tablets (70771-1119-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70771-1118-00 · Zydus 70771-1120-00 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.